The inhibition of autophagy sensitises colon cancer cells with wild-type p53 but not mutant p53 to topotecan treatment
about
Receptor interactive protein kinase 3 promotes Cisplatin-triggered necrosis in apoptosis-resistant esophageal squamous cell carcinoma cellsDevelopment of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenibTargeting of Topoisomerase I for Prognoses and Therapeutics of Camptothecin-Resistant Ovarian Cancer.Inhibition of autophagy exerts anti-colon cancer effects via apoptosis induced by p53 activation and ER stress.Role of autophagy-related protein expression in patients with rectal cancer treated with neoadjuvant chemoradiotherapyProteolytic systems and AMP-activated protein kinase are critical targets of acute myeloid leukemia therapeutic approaches.Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer.Downregulation of Beclin 1 and impairment of autophagy in a small population of colorectal cancer.Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer.Clinical relevance of autophagic therapy in cancer: Investigating the current trends, challenges, and future prospects.Three-dimensional microenvironment confers enhanced sensitivity to doxorubicin by reducing p53-dependent induction of autophagy.Therapeutic effects of the euglenoid ichthyotoxin, euglenophycin, in colon cancer.Targeting Autophagy in ALK-Associated Cancers.IGF1R upregulation confers resistance to isoform-specific inhibitors of PI3K in PIK3CA-driven ovarian cancer
P2860
Q33800218-A1FDF596-3ED3-4D47-A20A-1ED62B3668D0Q33878944-30FE0E0A-6ED7-49A9-9148-A2CEC8B69B29Q35711333-BCFA2369-0732-4356-B4C5-A3CCE67A7A2AQ35819410-5FEB9070-C16E-44CB-9010-BF50FD50ED74Q35953225-A2263444-C016-49F9-AECE-6A0ED599D900Q36544596-D03327DF-6B70-4AE7-9CBF-8B130E2F0767Q37018096-57AD09C6-CC71-4B1B-8BE9-68442C2E7DE2Q37192906-463CA191-5906-4D7D-A8CA-D678B8ED085BQ37536938-3BE85DCE-582D-4AF3-8464-FD88483FF3D0Q38689955-26A6CC6C-2047-4FFB-B321-F241E87199E3Q38916622-5CE6165B-D398-4C22-89CE-6EBB9DA40F51Q47126863-C0F925CA-76EE-4905-AE49-FFF290574437Q49545616-1A021658-0F72-4163-B0E6-655843D2062FQ58712237-09EFAEFA-EC4B-4702-89A4-50D5E830E892
P2860
The inhibition of autophagy sensitises colon cancer cells with wild-type p53 but not mutant p53 to topotecan treatment
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The inhibition of autophagy se ...... ant p53 to topotecan treatment
@ast
The inhibition of autophagy se ...... ant p53 to topotecan treatment
@en
The inhibition of autophagy se ...... ant p53 to topotecan treatment
@nl
type
label
The inhibition of autophagy se ...... ant p53 to topotecan treatment
@ast
The inhibition of autophagy se ...... ant p53 to topotecan treatment
@en
The inhibition of autophagy se ...... ant p53 to topotecan treatment
@nl
prefLabel
The inhibition of autophagy se ...... ant p53 to topotecan treatment
@ast
The inhibition of autophagy se ...... ant p53 to topotecan treatment
@en
The inhibition of autophagy se ...... ant p53 to topotecan treatment
@nl
P2093
P2860
P3181
P1433
P1476
The inhibition of autophagy se ...... ant p53 to topotecan treatment
@en
P2093
Dan-Dan Li
Gong-Kan Feng
Jing-Xuan Pan
Shan Jiang
Shu-Peng Chen
Xiao-Feng Zhu
Xiao-Qi Wu
Xiao-Shi Zhang
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0045058
P407
P577
2012-01-01T00:00:00Z